IPP Bureau
Sirio Pharma announces agreement to acquire best formulations
By IPP Bureau - July 10, 2022
The combined company will be able to better serve both our global and regional customers with local production
Dr. Reddy's Labs launches Fesoterodine Fumarate tablets in US
By IPP Bureau - July 10, 2022
Dr. Reddy's Fesoterodine Fumarate Extended-Release Tablets are available in 4 mg and 8 mg Tablets, each in bottle count sizes of 30.
Zydus launches Sitaglyn and Siglyn for the management of Type 2 diabetes
By IPP Bureau - July 10, 2022
The addition of Sitaglyn and Siglyn to our diabetes portfolio will give patients access to a world-class oral therapy to help people manage their diabetes
Mandaviya calls for collaboration to eliminate vector borne diseases
By IPP Bureau - July 10, 2022
China medical devices market to surpass $42 billion in 2022: GlobalData
By IPP Bureau - July 10, 2022
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Capnopharm to acquire operational assets of Capnomed
By IPP Bureau - July 10, 2022
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
WuXi XDC and AbTis sign MoU for manufacturing of antibody drug conjugates
By IPP Bureau - July 10, 2022
AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing
ALPLA acquires Polish packaging manufacturer APON
By IPP Bureau - July 08, 2022
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Evonik launches non-animal-derived collagen platform for medical device applications
By IPP Bureau - July 08, 2022
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Dr. Reddy's Laboratories updates on PAI of formulations facility
By IPP Bureau - July 08, 2022
The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.
US FDA Inspection at Alkem's Indore manufacturing facility
By IPP Bureau - July 08, 2022
This GMP and Pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline
Lupin’s Somerset manufacturing plant Receives EIR from US FDA
By IPP Bureau - July 08, 2022
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Glenmark launches Sitagliptin and its FDC at affordable price
By IPP Bureau - July 08, 2022
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
WuXi STA opens Oligonucleotide and Peptide manufacturing facility
By IPP Bureau - July 08, 2022
Site Enhances New Modality CRDMO Platform Capacity for Customers
IIT Delhi-backed startup develops antimicrobial solution for textiles
By IPP Bureau - July 07, 2022
Medicfibers in collaboration with AIIMS New Delhi, has developed an antimicrobial solution Viroclog that when applied as a coating on textiles, provides long-lasting protection against HAI by reducing virus, bacteria, fungi survival on fabric
